share_log

Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M

Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M

Estrella Biopharma, Inc. 將通過與TradeUp Acquisition Corp. 的合併成爲一家上市公司;合併後的公司的預計股權估值(假設沒有贖回)預計約爲3.985億美元
Benzinga Real-time News ·  2022/10/03 07:31

Estrella Biopharma, Inc. To Become A Publicly Traded Company Via Merger With TradeUP Acquisition Corp.; The Pro Forma Equity Valuation (Assuming No Redemptions) Of The Combined Company Is Expected To Be ~$398.5M

Estrella Biopharma, Inc. 將通過與TradeUp Acquisition Corp. 的合併成爲一家上市公司;合併後的公司的預計股權估值(假設沒有贖回)預計約爲3.985億美元

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論